An open-label study of olanzapine in the first episode of schizophrenia in adolescents

被引：0
|
作者：
Dabokowska, M [1 ]
机构：
[1] Med Acad, Dept Psychiat, Bydgoszcz, Poland
来源：
EUROPEAN PSYCHIATRY | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：115S / 115S
页数：1
相关论文
共 50 条
  • [1] A prospective, open-label trial of olanzapine in adolescents with schizophrenia
    Findling, RL
    McNamara, NK
    Youngstrom, EA
    Branicky, LA
    Demeter, CA
    Schulz, SC
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (02): : 170 - 175
  • [2] THE OPTIMISE STUDY: AMISULPRIDE AND OLANZAPINE FOLLOWED BY OPEN-LABEL TREATMENT WITH CLOZAPINE IN FIRST-EPISODE SCHIZOPHRENIA
    Arango, Celso
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S115 - S115
  • [3] Childhood-onset schizophrenia: An open-label study of olanzapine in adolescents
    Kumra, S
    Jacobsen, LK
    Rapoport, JL
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 149 - 149
  • [4] Childhood-onset schizophrenia: An open-label study of olanzapine in adolescents
    Kumra, S
    Jacobsen, LK
    Lenane, M
    Karp, BI
    Frazier, JA
    Smith, AK
    Bedwell, J
    Lee, P
    Malanga, CJ
    Hamburger, S
    Rapoport, JI
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1998, 37 (04): : 377 - 385
  • [5] Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: An open-label trial
    Takahashi, Hitoshi
    Kamata, Mitsuhiro
    Yoshida, Keizo
    Ishigooka, Jun
    Higuchi, Hisashi
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (10) : 1577 - 1582
  • [6] Open-label randomized trial comparing the efficacy and tolerability of quetiapine and olanzapine in first episode psychosis in adolescents
    Parellada, M. J.
    Moreno, D.
    Ruiz-Sancho, A.
    Medina, O.
    Arango, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S377 - S378
  • [7] Plasma levels of olanzapine: Findings from an open-label study of adolescents and young adults with schizophrenia
    Dittmann, R
    Clement, H
    Knebel, W
    Roesch, F
    Hagenah, U
    Junghanss, J
    Maestele, A
    Mehler, C
    Meyer, C
    Pitzer, M
    Remschmidt, H
    Schlamp, D
    Schulte-Markwort, M
    Weiffenbach, O
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 481 - 481
  • [8] Olanzapine in treatment-refractory schizophrenia: Results of an open-label study
    Martin, J
    Gomez, JC
    GarciaBernardo, E
    Cuesta, M
    Alvarez, E
    Gurpegui, M
    JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (11) : 479 - 483
  • [9] Olanzapine efficacy and tolerability in adolescents with schizophrenia: results from an open-label extension phase
    Robertson-Plouch, Carol
    Kryzhanovskaya, Ludmila
    Schulz, Charles
    McDougle, Christopher
    Frazier, Jean
    Xu, Wen
    Carlson, Janice
    Tohen, Mauricio
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) : 879 - 879
  • [10] Olanzapine efficacy and tolerability in adolescents with schizophrenia: Results from an open-label extension phase
    Robertson-Plouch, Carol
    Kryzhanovskaya, Ludmila
    Schulz, Charles
    McDougle, Christopher J.
    Frazier, Jean A.
    Xu, Wen
    Carlson, Janice
    Tohen, Mauricio
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S215 - S216
12345